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Repeated measures are increasingly collected in a study to investigate the trajectory of measures over time. One of the ﬁrst research
questions is to determine the correlation between two measures. The following ﬁve methods for correlation calculation are
compared: (1) Pearson correlation; (2) correlation of subject means; (3) partial correlation for subject eﬀect; (4) partial correlation
for visit eﬀect; and (5) a mixed model approach. Pearson correlation coeﬃcient is traditionally used in a cross-sectional study.
Pearson correlation is close to the correlations computed from mixed-eﬀects models that consider the correlation structure, but
Pearson correlation may not be theoretically appropriate in a repeated-measure study as it ignores the correlation of the outcomes
from multiple visits within the same subject. We compare these methods with regard to the average of correlation and the mean
squared error. In general, correlation under the mixed-eﬀects model with the compound symmetric structure is recommended as
its correlation is close to the nominal level with small mean square error.

1. Introduction
Repeated-measure designs are increasingly used in practice
to evaluate the trajectory of measures. The Alzheimer’s
Disease Neuroimaging Initiative (ADNI) study is a longitudinal study to investigate the progression of Alzheimer’s
disease (AD) [1, 2]. This study evaluates the normal cognitive
aging with the focus on mild cognitive impairment (MCI)
and early AD. Brain structure and function are two research
areas of interest in the ADNI study. As expected, brain
structure volumes are often highly associated with results
from cognitive tests [3–5]. In a longitudinal study, correlation for repeated measures should be calculated and reported. However, recent articles still only reported the
Pearson correlation coeﬃcient that ignores the correlation of
outcomes from the same subject. For these reasons, it is
important to compare the existing correlations for repeated
measures and make recommendations for other researchers
to use.
Bland and Altman [6, 7] discussed several approaches to
compute correlations for repeated measures. They proposed
calculating subject means to compute the Pearson

correlation, where subject means eliminate the correlation of
outcomes from the same subject. The second approach is to
ﬁt a linear regression model with one measure as the dependent variable and the other measure and the subject as
the predictor variables. The second approach is similar to the
one proposed by Christensen [8] who suggested computing
correlation after adjusting for the subject eﬀect [9–12]. In a
repeated-measure study, the visit eﬀect is the correlation
within the subject. Lipsitz et al. [13] proposed computing
partial correlation adjusting the visit eﬀect. When data are
correlated, mixed-eﬀects models may be utilized to analyze
data while controlling for these additional correlations. Lam
et al. [14] were among the ﬁrst to propose computing
correlation between repeated measures under the compound
symmetric (CS) correlation structure. Later, Hamlett et al.
[15] developed programs to compute correlation under the
CS structure by using the commercially available statistical
software, SAS. In the work by Lam et al. [14], they also
computed the correlation under the autoregressive correlation structure, AR(1). After that, Roy [16] developed SAS
macros to compute correlation under the AR(1) structure
and compared the correlations for repeated measures under
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these two correlation structures with limited simulation
studies.
The objective of this manuscript is to conduct extensive
simulation studies to compare the existing correlations for
repeated measures with regard to the average of correlation
and the mean squared error (MSE) and identify the correlation method that has the best performance to be used in
practice. In addition to the parameter of interest (correlation
for repeated measures), there are several nuisance parameters in the variance-covariance matrix: variances, correlations within each outcome, and correlation between
outcomes from diﬀerent visits [17–20]. It is computationally
intensive for these comparisons. We have to use supercomputers for simulation studies. However, it is computationally feasible to calculate correlations for an observed data
set. We use one example from the ADNI study to illustrate
the application of the considered methods to calculate
correlation between hippocampal volumes and a neuropsychological assessment to evaluate verbal memory.
We organize this article as follows. In Section 2, we
introduce the existing methods to calculate correlations for
repeated measures. In Section 3, we conduct extensive
Monte Carlo simulation studies to compare the performance
of the considered correlations with regard to the average of
correlation and the MSE. A real example from the ADNI
study is then used to illustrate the application of these
correlations. Lastly, we provide conclusions in Section 4 on
computing correlation for repeated measures when heterogeneity of correlation is observed across visits.

2. Methods
For a repeated-measure study with n participants, each
participant has several scheduled visits (mi visits for the i-th
subject). Suppose U and W are the two measures in a repeated-measure study and Uij and Wij are the outcomes of
the i-th subject at the j-th visit, where i � 1, 2, . . ., n and j � 1,
2, . . ., mi. The correlation between U and W, ρUW , is the
parameter of interest to quantify a relationship between
them. Several methods have been proposed to calculate ρUW ,
including independence models, partial correlation models,
and mixed-eﬀects models.
2.1. Independent Assumption. Bland and Altman [6, 7] were
among the ﬁrst to provide methods to compute longitudinal
correlation coeﬃcient. One of their approaches assumes the
independence between outcomes from the same subject: Uij
⊥ Uij′ and Wij ⊥Wij . The longitudinal correlation ρUW is
′
computed as the Pearson
correlation by ignoring the correlation structure from repeated measures. This approach is
referred to as the I approach, with the computed correlation
as ρI . This is a naive approach that is easy to apply. Irimata
and Li [21] found that ρI for a pharmacokinetics data set is
very close to other correlations computed from other
complicated models.
2.2. Subject Means. As suggested by Bland and Altman [6],
the correlation can be computed by using the averages at the
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subject level to eliminate the subject eﬀect in repeated
measures. This correlation is able to address the research
question whether the average of one measure is related to the
average of another. When correlation within each measure is
large, ρUW at diﬀerent visits should be similar to each other,
and this average correlation model would have good performance. We refer to this correlation approach as the M
approach with the notation of ρM .
These two correlations for repeated measures, ρI and ρM ,
are the Pearson correlation and can be computed by using
many statistical software: such as the Proc corr procedure in
SAS and the function cor or cor.test in R [22]. The next ﬁve
correlations are computed from regression models (e.g.,
mixed-eﬀects models), and we would like to suggest using
SAS Proc mixed procedure for implementation. Detailed
SAS programs are provided in the Appendix.
2.3. Correlation Adjusting for the Subject Eﬀect.
Christensen [8] proposed computing correlation for repeated measures by partialling out the subject eﬀect. The
subject eﬀect can be removed from the two measures by
ﬁtting a multivariate regression model with both measures
being the outcomes and the subject ID as the only covariate.
The residuals are used to compute the ﬁnal correlation,
which is essentially a partial correlation method for repeated
data. This correlation is referred to as the PS correlation that
partials out the subject eﬀect, ρPS .
2.4. Correlation Adjusting for the Visit Eﬀect. In the ρPS
calculation, the correlation between the two measures is
included in the multivariate model. In addition to that
correlation, another correlation between measures at different visits may be considered. Lipsitz et al. [13] proposed
computing partial correlation between outcome and one of
the covariates by using this approach. When one of the two
measures (e.g., measure U) is considered as the dependent
variable, the other measure (W) is considered as the covariate. The correlation structure between visits is assumed
to be compound symmetric. We refer this correlation as the
ρPVa correlation. We use ρPVb for another correlation when
W is considered as the dependent variable in the model. One
of the properties for correlation is ρUW � ρWU , but this
property is not met here: ρPVa is generally not equal to ρPVb .
2.5. Mixed-Eﬀects Model. Let Yi � (Ui1 , Wi1 , Ui2 , Wi2 , . . . ,
Uimi , Wimi ) be the outcomes from the i-th subject, with the
vector length of 2mi. The complete data can be reorganized
in a long format, with the columns subject ID, visit, mtype,
and outcome, where mtype � “U” for the U measure and
mtype � “W” for the W measure. The long format utilizes
2mi rows for the outcomes from Yi.
The linear mixed-eﬀects model is presented as
Yi � Xi β + Zi bi + ϵi ,

(1)

where Xi and Zi are the design matrices for the ﬁxed eﬀect
and the random eﬀect, respectively. The random eﬀect bi
follows a multivariate normal distribution N (0, D), and the
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measurement error ϵi follows a multivariate normal distribution N (0, Ri). The detailed formula for D and Ri may be
found in the article by Hamlett et al. [15]. The ﬁxed eﬀect is
β � (β0, βU, βW)′, where β0 is the intercept, and βU and βW
are the ﬁxed eﬀects of U and W, respectively. Correlation
between U and W is computed as
ρUW � Corr(U, W),

(2)

which is assumed to be independent of the visit.
Each subject has multiple visits, correlation within U is
d(j−j′)

Corr(Uij , Uij′ ) � ρU

, and the correlation within W is

d(j−j′)
ρW
,

Corr(Wij , Wij′ ) �
where d (j − j′) � 1 for the CS
structure and d (j − j′) � |j − j′| for the AR(1) structure. Since
Wij is correlated with both Uij and Wij′ , therefore, Uij and
Wij′ are correlated and their correlation is assumed to be
δρUW, where δ is a factor which is generally less than 1. Let
σ 2U and σ 2W be the variances of U and W, respectively. These
variances and covariances are used to derive the variancecovariance matrix under the CS structure (see Lam et al. [14]
and Hamlett et al. [15]) and that under the AR(1) structure
(see Lam et al. [14] and Roy [16]).

3. Results
We conduct simulation studies to compare the performance
of the considered 7 methods for the correlation between
repeated measures for a study with four visits. The mean
values of U and W are assumed to be (2.0, 1.9, 1.7, 1.4) and
(0.8, 0.7, 0.6, 0.5), with both measures decreasing as time
goes. Such data are commonly available from cognitive tests
on elderly population and other studies. The prespeciﬁed
correlation for repeated measures is ρUW � 0.2, 0.5, and 0.8.
In the simulation studies for the AR(1) structure for the
|j−j′|

visit eﬀect, the correlation within U is Corr(Uij , Uij′ ) � ρU ,
with ρU � 0.2, 0.5, and 0.8, and the correlation within W is
|j−j′|

Corr(Wij , Wij′ ) � ρW , with ρW � 0.2, 0.5, and 0.8. The
factor δ in the correlation between Uij and Wij′ is assumed to
be 0.6 in all simulations. The considered variances are σ 2U � 1
and 3 and σ 2W � 0.5 and 1. The variance-covariance matrix can
be separated into two parts: Zi DZ′i and Ri. We assume that a
quarter of variance is from Ri and the remaining is from Zi DZ′i.
This weight is needed in order to calculate the covariances. For
each conﬁguration, we simulate B � 2,000 data sets.
Under the AR(1) structure for the visit eﬀect, Figure 1
presents the average of correlation ρUW and the MSE when
ρUW � 0.2, σ 2U � 1, and n � 60 subjects. The MSE is deﬁned
as
MSE �

1 B
2
 ρ (b) − ρUW  ,
B b�1 UW

(3)

where ρUW (b) is the estimator of ρUW by using the b-th
simulated data set. It can be seen that the correlations
adjusting the visit eﬀect, ρPVa and ρPVb , often underestimate
the correlation, while the correlation adjusting the subject
eﬀect, ρPS , always overestimate the correlation. The remaining

methods have correlations close to the nominal level. Although
ρM is the best with the correlation around the nominal level, its
MSE is much larger than the ones that have the correlations
close to the nominal level. In the calculation of ρM , each subject
only has one outcome for each measure, as compared to
multiple outcomes in other correlation calculations. Due to the
reduced number of outcomes, the variance of ρM is much large
that leads to a large MSE. It is noted that ρPVa or ρPVb could
have the lowest MSE in some cases, but their estimated correlations are generally much below the nominal level. For this
reason, we exclude ρPVa and ρPVb in the following simulation
studies. When a study has the same number of visits for each
subject, the estimated correlation by using the mixed-eﬀects
model with the CS structure, ρCS , is very similar to ρI under the
independent assumption. The other mixed-eﬀects model
correlation ρAR has a similar correlation as ρCS and ρI . The
MSE of ρAR is slightly smaller than the MSEs of ρCS and ρI
when the correlations within U or W are small, and this trend is
reversed when ρU and ρW are large. Similar results are observed
when σ 2U is increased to 3.
When ρU is increased to 0.5 (the top plot in Figure 2), the
averages of ρI , ρCS , and ρAR are generally above the nominal
level, and the ﬁrst two correlations are closer to the nominal
level as compared to the third correlation ρAR . We also present
the correlation estimates when sample size n is 100 in Figure 2.
It can be seen that the MSEs become smaller as compared to the
MSEs in the top plot (Figure 2) when sample size is 60.
Figure 3 shows the results when data sets are simulated
under the CS structure given ρU � 0.5, σ 2U � 1, and n � 60.
Correlation ρPS does not perform well with the average
correlations much below the nominal level in many conﬁgurations. We also found that ρM is likely to overestimate
the correlation. It seems that ρM and ρPS have diﬀerent
trajectories as ρW increases. Both of these methods do not
have satisfactory performance with regard to correlation
under the CS structure, although ρPS has very good correlation estimates under the AR(1) structure. The other three
correlations (ρI , ρCS , and ρAR ) have similar good performance with regard to correlation and the MSE. It should be
noted that the variance-covariance matrix is not positively
deﬁned when ρU � ρW � 0.8. Therefore, data sets cannot be
generated for that conﬁguration. We also simulate data
under the unstructured correlation structure and found that
ρI , ρCS , and ρAR are still the best correlation estimates.
The aforementioned simulations have data sets that each
subject has the same number of visits. In practice, it is
possible that the number of visits may not be exactly the
same for all subjects. We assume the number of visits is
either 2, 3, or 4. Each subject is randomly assigned to have 2,
3, or 4 visits with the same probability. We present the
results with n � 60 in Figure 4 when variances are small
(σ 2U � 1 and σ 2W � 0.5 and 1) and large (σ 2U � 20 and σ 2W � 10
and 30). The MSE of ρCS is slightly smaller than that of ρI,
and their biggest diﬀerence occurs when both ρU and ρW are
large. ρAR is more likely to overestimate the correlation.
Although ρM has the correlation very close to the nominal
level, it has the largest MSE as compared to other correlations. When variance is large, ρI and ρCS are the best correlations with the estimated correlations much closer to the
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Figure 1: Average correlation and the MSE for the 7 methods under the AR(1) correlation structure when ρUW � 0.2, σ 2U � 1, and n � 60.

nominal level as to the conﬁgurations with small variances.
The mixed-eﬀects model correlation ρCS performs slightly
better than ρI with regard to the average of correlation and
the MSE.
3.1. Example. We use one data set from the ADNI study to
illustrate the application of the considered correlation

methods, with 47 participants who had 5-year visits and
completed imaging volumes and memory scores. Hippocampal volumes are found to be highly associated with the
delayed recall scores from the Rey Auditory Verbal Learning
Test (RAVLT delayed recall) [23]. The RAVLT delayed recall
has the possible integer score from 0 to 15, which is often
used to assess verbal memory. The higher the score is, the
better the memory is.
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Figure 2: Continued.
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Figure 2: Average correlation and the MSE under the AR(1) correlation structure with n � 60 (top) and n � 100 (bottom) when ρUW � 0.5
and σ 2U � 1.

The computed correlations are presented in Table 1.
Participants in this data set have the same number of visits.
For this reason, ρI is very similar to ρCS . ρM is slightly larger
than them, and ρAR is smaller than them. Correlation adjusted by the subject eﬀect ρPS is much smaller than ρCS .
Correlations adjusted by the visit eﬀect highly depend on
which variable is considered as the dependent variable in the
linear regression model. When hippocampal volumes are
used as the dependent variable, the estimated correlation is

high (0.686), and it becomes too low (0.016) when RAVLT
delayed recalls are considered as the dependent variable.
It was reported by Wang et al. [23] that the Pearson
correlation ρI between hippocampal volumes and RAVLT
delayed recall scores is slightly above 0.4. They also provided
the Pearson correlations for each group (AD, MCI, and
control) which are all below the correlation using combined
samples. The correlation within the control group is the
lowest.
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Figure 3: Average correlation and the MSE under the CS correlation structure when ρUW � 0.5, σ 2U � 1, and n � 60.
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Figure 4: Continued.
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Figure 4: Average correlation and the MSE under the AR(1) correlation structure with a small variance σ 2U � 1 (top) and a large variance
σ 2U � 20 (bottom) when ρUW � 0.5 and n � 60 for a study with unequal numbers of visits (2, 3, or 4 visits).

Table 1: Correlation between hippocampal volumes and RAVLT delayed recall scores using 47 participants with 5 visits from the ADNI
study.

Left hippocampal and RAVLT delayed recall scores
Left hippocampal and RAVLT immediate recall scores
Right hippocampal and RAVLT delayed recall scores
Right hippocampal and RAVLT immediate recall scores

ρI

ρM

ρPS

ρPVa

ρPVb

ρCS

ρAR

0.421
0.352
0.361
0.316

0.468
0.421
0.398
0.373

0.151
0.208
0.149
0.211

0.016
0.023
0.014
0.021

0.686
0.447
0.652
0.443

0.421
0.365
0.361
0.335

0.392
0.399
0.327
0.343
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From Table 1, RAVLT delayed recall scores always have a
larger correlation with left hippocampal volumes than the
correlation with right hippocampal volumes for each correlation method. We also add RAVLT immediate recall
scores to further illustrate the application of the considered
methods. Its correlation with left hippocampal volumes is
often larger than its correlation with right hippocampal
volumes. The estimated ρCS between hippocampal volumes
and RAVLT delayed recalls is larger than that between
hippocampal volumes and RAVLT immediate recalls.

Computational and Mathematical Methods in Medicine
investigators within the ADNI contributed to the design and
implementation of ADNI and/or provided data but did not
participate in analysis or writing of this report. A complete
listing of ADNI investigators can be found at http://adni.
loni.usc.edu/wp-content/uploads/how_to_apply/
ADNI_Acknowledgement_List.pd.
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4. Conclusions
From the simulation studies, ρI under the independence
assumption and ρCS using the mixed-eﬀects model with CS
variance-covariance structure are shown to have similar
correlation estimates when subjects have the same number
of visits. But, ρCS is appropriate as it models the data
properly. The mixed-eﬀects model correlation ρCS is recommended for use as its correlation is close to the nominal
level with small mean square error.
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study has a monotonic relationship between correlation
and visit, one may include an additional predictor: visit, in
the statistical model, to calculate a monotonic correlation
for repeated measures.
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Data Availability

Supplementary Materials

The data used in preparation of this article were obtained
from the Alzheimer’s Disease Neuroimaging Initiative
(ADNI) database (http://adni.loni.usc.edu). As such, the

Supplement is the R code. SAS programs: correlation for
repeated measures from 8 critically ill patients: pH and
PaCO2 [6]. (Supplementary Materials)
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